India  

COVID-19: India gives nod to AstraZeneca's Covishield vaccine for mass immunisation

DNA Saturday, 2 January 2021
It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: India's 'good news' on New Year: Vaccine nod soon? | Oneindia News

India's 'good news' on New Year: Vaccine nod soon? | Oneindia News 01:22

A vaccine nod seems imminent in India as we enter the new year. At an event on Thursday December 31st, Drugs Controller General Dr VG Somani had said: "Probably we will have a happy New Year with something in hand." The Prime Minister also said India enters the New Year with hope for treatment as...

💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

‘Covid vaccination done for free at govt hospitals in India’: PM Modi [Video]

‘Covid vaccination done for free at govt hospitals in India’: PM Modi

Prime Minister Narendra Modi said Covid-19 vaccination was being done for free at government hospitals. PM Modi was addressing Janaushadhi Diwas celebrations via video conferencing. “We are proud of our scientists for we now have ‘Made in India’ vaccine for us and the rest of the world. Covid-19 vaccination is being done for free at government hospitals in India. Covid-19 vaccine costs Rs 250 in private hospitals which is the cheapest in world. Even I got my first dose of Covid-19.” PM Modi added, “1.5 lakh health and wellness centre are being made in villages out of which 50,000 have already started functioning. These centres will be equipped to tackle serious health issues.” Watch the full video for more.

Credit: HT Digital Content    Duration: 02:15Published
COVID vaccination done for free at govt hospitals in India: PM Modi [Video]

COVID vaccination done for free at govt hospitals in India: PM Modi

Prime Minister Narendra Modi inaugurated 7500th Janaushadhi Kendra at North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS) in Shillong. The event took place via video conferencing on March 07. While addressing the event, PM Modi said, "Today, we have 'Made in India' vaccines for our country and for the world. COVID-19 vaccination is being done for free at government hospitals and at the cost of Rs 250 at private hospitals. I have also taken the first dose of the COVID-19 vaccine."

Credit: ANI    Duration: 01:51Published
COVID-19: India records over 2.9 crore vaccination [Video]

COVID-19: India records over 2.9 crore vaccination

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on March 07 reported single-day spike of 18,711 new coronavirus cases in the last 24 hours. 100 deaths in the same period pushed the COVID-19 toll in the country to 1,57,756. India's confirmed cases of coronavirus stand at 1,12,10,799 which include 1,84,523 active infections. More than 1,08,68,520 people have recovered from the virus with 14,392 new discharges in last 24 hours. Till date the total vaccination is 2,09,22,344. According to Indian Council of Medical Research (ICMR), a total of 7,37,830 samples were tested on March 06. Cumulative samples tested for COVID-19 till March 06 are 22,14,30,507.

Credit: ANI    Duration: 01:48Published

AstraZeneca British-Swedish pharmaceutical company

AstraZeneca effective against Brazil variant – source [Video]

AstraZeneca effective against Brazil variant – source

Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian variant of the disease. Colette Luke has more.

Credit: Reuters Studio    Duration: 01:31Published
EU, Italy stop AstraZeneca vaccine exports to Australia [Video]

EU, Italy stop AstraZeneca vaccine exports to Australia

Credit: FRANCE 24 English    Duration: 01:44Published
Australia appeals to EU over Italy's vaccine block [Video]

Australia appeals to EU over Italy's vaccine block

Australia has asked the European Commission to review a decision by Italy to block a shipment of AstraZeneca's COVID-19 vaccine, while stressing on Friday the missing doses would not affect the rollout of Australia's inoculation programme. Flora Bradley-Watson reports.

Credit: Reuters - Politics    Duration: 01:25Published

Australia hits back as EU stops vaccine delivery, with bloc accused of 'tearing up the rule book'

Australia has hit back at the EU's move to block a shipment of the Oxford/AstraZeneca vaccine - suggesting the bloc was trying to "tear up the rule book". 
Sky News

You Might Like


Related videos from verified sources

All India vaccine test run on January 8th ahead of rollout | Oneindia news [Video]

All India vaccine test run on January 8th ahead of rollout | Oneindia news

India is gearing up to hold a third and possibly final Covid-19 vaccine dry run on 8 January in all 718 districts; The Supreme Court will on January 11 hear a batch of pleas challenging the new farm..

Credit: Oneindia     Duration: 02:24Published
Covid vaccine: In Gujarat, European firm unveils tech to store, transport doses [Video]

Covid vaccine: In Gujarat, European firm unveils tech to store, transport doses

As India approves vaccines, storage & transportation tech unveiled. Luxembourg-based B. Medical Systems launched equipment in Ahmedabad. India was in talks with the foreign firm to set up vaccine cold..

Credit: HT Digital Content     Duration: 02:32Published
Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains [Video]

Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains

ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine..

Credit: HT Digital Content     Duration: 04:32Published

Related news from verified sources

Britain approves Moderna's Covid-19 vaccine for use

Britain's medical regulator on Friday approved Moderna's Covid-19 vaccine for use, the health ministry said, adding that it had agreed to purchase an additional...
IndiaTimes Also reported by •Indian ExpressHinduMid-Day

Breaking: SEC recommends Serum Institute of India vaccine for use in India

The Subject Experts Committee (SEC) has recommended covidshield to DCGI for use against COVID-19 virus in India.
DNA

World facing 'catastrophic' moral failure on vaccines: WHO chief

The world is on the "brink of a catastrophic moral failure" if rich countries hog Covid-19 vaccine doses while the poorest suffer, the head of the WHO said...
IndiaTimes